We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bausch Health Cos | NYSE:VRX | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 23.40 | 0.00 | 01:00:00 |
LAVAL, Quebec, May 19, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of eleven directors nominated at its 2015 annual meeting of shareholders today. The detailed results of the vote for the election of directors are set out below:
Name |
For |
Withheld |
Broker Non-Votes |
||||
Ronald H. Farmer |
259,517,209 |
2,064,596 |
12,938,661 |
||||
Colleen A. Goggins |
260,564,263 |
1,017,542 |
12,938,661 |
||||
Robert A. Ingram |
258,725,145 |
2,856,660 |
12,938,661 |
||||
Anders Lönner |
259,632,031 |
1,949,774 |
12,938,661 |
||||
Theo Melas-Kyriazi |
260,811,015 |
770,790 |
12,938,661 |
||||
J. Michael Pearson |
255,809,687 |
5,772,118 |
12,938,661 |
||||
Robert N. Power |
258,849,981 |
2,731,824 |
12,938,661 |
||||
Norma A. Provencio |
260,777,276 |
804,529 |
12,938,661 |
||||
Howard B. Schiller |
250,437,448 |
11,144,357 |
12,938,661 |
||||
Katharine B. Stevenson |
260,656,695 |
925,110 |
12,938,661 |
||||
Jeffrey W. Ubben |
260,166,082 |
1,415,723 |
12,938,661 |
At the annual meeting, shareholders also approved the non-binding advisory vote on named executive officer compensation as disclosed in the proxy statement and appointed PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the Company's 2016 annual meeting of shareholders.
The final vote tabulation on all matters voted on at today's meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K and such report will be made available on the Company's web site, www.valeant.com.
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com
Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-2015-annual-meeting-results-300085929.html
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright 2015 PR Newswire
1 Year Valeant Pharma Chart |
1 Month Valeant Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions